Name: Antiplatelets and Anticoagulants
Creator: C. Richard Conti
Keywords: 03 medical and health sciences, Treatment Outcome, 0302 clinical medicine, Cardiovascular Diseases, Anticoagulants, Humans, Hemorrhage, Risk Assessment, Platelet Aggregation Inhibitors, 3. Good health

descriptionPublicationkeyboard_double_arrow_right Article , Other literature type 01 Jul 2010 English Publisher:WileyJournal:Clinical Cardiology, volume 33, pages 388-389 (issn: 0160-9289, eissn: 1932-8737,

Authors: C. Richard Conti;

doi: 10.1002/clc.20820

pmid: 20641114

pmc: PMC6653116

Antiplatelets and Anticoagulants

- Summary
- Subjects
- Metrics

Abstract

AbstractThose of us who see patients with cardiovascular disorders frequently use antiplatelet and anticoagulant agents; the common agents are aspirin, clopidogrel, and warfarin. This editorial is a personal viewpoint about commonly used drugs, not so commonly used drugs, and drugs that are yet to be used clinically. Copyright © 2010 Wiley Periodicals, Inc.

Keywords

Treatment Outcome, Cardiovascular Diseases, Anticoagulants, Humans, Hemorrhage, Risk Assessment, Platelet Aggregation Inhibitors

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average